Digital Diagnostics Inc.
  1. Companies
  2. Digital Diagnostics Inc.
  3. Products
  4. Digital Diagnostics - Model IDx-DR - AI ...

Digital DiagnosticsModel IDx-DR - AI Diagnostic System

SHARE

IDx-DR is an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy (including macular edema)

Most popular related searches

Safety
IDx-DR was validated against patient outcomes using a surrogate outcome standard to keep patient safety the main priority. In the pivotal clinical trial, IDx-DR referred 100% of patients with at least moderate diabetic retinopathy and more than 96% of patients with diabetic macular edema.

Effective
In our pivotal clinical trial, IDx-DR avoided 91% of unnecessary specialty visits by capturing a result that is negative for diabetic retinopathy (including macular edema) at the point-of-care.

Equitable
IDx-DR has been trained and validated on over 2M images to mitigate bias and ensure the system works equally well for all people, regardless of sex, race, or ethnicity. For more information, read our pivotal trial.

Front-Line Care Providers

IDx-DR is for medical professionals who want to provide patients with rigorously validated and ethically designed diagnostic results at the point-of-care, allowing for more comprehensive diabetes care and improved performance with diabetic eye exam quality measures.

Ophthalmologists & Optometrists

IDx-DR is for eye care providers to help address disparities and improve equity in care as part of the diabetic eye exam delivery model. IDx-DR outputs can direct more actionable referrals, identifying patients with diabetes, not already under the care of an eye care provider, who are most likely to need timely vision saving interventions.

Payor Community

IDx-DR is for payors to improve healthcare efficiency and access to care for enrollees while supporting the Patient Centered Medical Home (PCMH).

  • Cost savings over the life-time of care
  • Prevent blindness through early disease detection
  • 100% compliance for DR alone saves > $5B/year
Patients

IDx-DR is for adults (22 years of age or older) diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy or macular edema and are not currently under the care of an eye care specialist. IDx-DR is installed at point-of-care locations to increase patient access and convenience.

AI the Right Way
IDx-DR is modeled to look for and make decisions based on the same clinical disease detectors that eye care specialists would use.

  • Diagnostic AI built on an ethical foundation
  • Diagnostic results at the point-of-care
  • Infinitely scalable

  • Diagnostic results at the point-of-care
  • No need for specialist overread or telemedicine call backs
  • A simple user interface
  • Customized workflow integration solutions